Korro Bio, Inc.·4

Apr 23, 5:25 PM ET

FORMELA JEAN FRANCOIS 4

4 · Korro Bio, Inc. · Filed Apr 23, 2024

Insider Transaction Report

Form 4
Period: 2024-04-22
Transactions
  • Award

    Common Stock

    2024-04-22$56.00/sh+17,857$999,992195,074 total(indirect: See footnote)
Holdings
  • Common Stock

    (indirect: See footnote)
    942,075
Footnotes (2)
  • [F1]These shares are held directly by Atlas Venture Opportunity Fund II, L.P. ("AVOF II"). Atlas Venture Associates Opportunity II, L.P. ("AVAO II LP") is the general partner of AVOF II. Atlas Venture Associates Opportunity II, LLC ("AVAO II LLC") is the general partner of AVAO II LP. The Reporting Person is a member of AVAO II LLC and disclaims Section 16 beneficial ownership of such shares, except to the extent of his pecuniary interest therein, if any.
  • [F2]These shares are held directly by Atlas Venture Fund XI, L.P. ("Atlas XI"). Atlas Venture Associates XI, L.P. ("AVA XI LP") is the general partner of Atlas XI. Atlas Venture Associates XI, LLC ("AVA XI LLC") is the general partner of AVA XI LP. The Reporting Person is a member of AVA XI LLC and disclaims Section 16 beneficial ownership of such shares, except to the extent of his pecuniary interest therein, if any.

Documents

1 file
  • 4
    form4-04232024_090441.xmlPrimary